These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8086548)

  • 1. Pseudomonas aeruginosa bacteremia in patients with AIDS.
    Mendelson MH; Gurtman A; Szabo S; Neibart E; Meyers BR; Policar M; Cheung TW; Lillienfeld D; Hammer G; Reddy S
    Clin Infect Dis; 1994 Jun; 18(6):886-95. PubMed ID: 8086548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacteremia caused by Pseudomonas aeruginosa in patients with AIDS].
    Bouza Santiago E; Blázquez Garrido R; Rodríguez-Creixems M; Moreno Guillén S; Miralles Martín P; Alonso Fernández R
    Rev Clin Esp; 1996 Oct; 196(10):698-702. PubMed ID: 9005473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.
    Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Macas A; Sakalauskas R
    Medicina (Kaunas); 2010; 46(7):490-5. PubMed ID: 20966623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study.
    Paulsson M; Granrot A; Ahl J; Tham J; Resman F; Riesbeck K; Månsson F
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1187-1196. PubMed ID: 28110415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteremia due to Pseudomonas aeruginosa in children with AIDS.
    Flores G; Stavola JJ; Noel GJ
    Clin Infect Dis; 1993 May; 16(5):706-8. PubMed ID: 8507763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy.
    Tuon FF; Gortz LW; Rocha JL
    Braz J Infect Dis; 2012; 16(4):351-6. PubMed ID: 22846123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients.
    Meynard JL; Barbut F; Guiguet M; Batisse D; Lalande V; Lesage D; Guiard-Schmid JB; Petit JC; Frottier J; Meyohas MC
    J Infect; 1999 May; 38(3):176-81. PubMed ID: 10424798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Streptococcus pneumoniae bacteremia and HIV infection. Retrospective study of 41 episodes in 30 patients].
    Torri O; Mariel C; Veyssier P; Cevallos R; Bouchaud O; Carbon C; Jarousse B; Masson H; Patey O; Fantin B
    Presse Med; 1994 Jun; 23(21):972-5. PubMed ID: 7937643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.
    Morata L; Cobos-Trigueros N; Martínez JA; Soriano A; Almela M; Marco F; Sterzik H; Núñez R; Hernández C; Mensa J
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4833-7. PubMed ID: 22751533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey.
    Manfredi R; Nanetti A; Ferri M; Chiodo F
    Eur J Epidemiol; 2000 Feb; 16(2):111-8. PubMed ID: 10845259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy.
    Siegman-Igra Y; Ravona R; Primerman H; Giladi M
    Int J Infect Dis; 1998; 2(4):211-5. PubMed ID: 9763504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pseudomonas aeruginosa bacteremia in patients with HIV infection: clinicoepidemiologic study of 17 episodes].
    Salavert Lletí S; Navarro Ibáñez V; Roig Rico P; Bretón Martínez JR; Ponz Díez F; López Aldeguer J; Gobernado Serrano M
    Rev Clin Esp; 1996 Oct; 196(10):684-91. PubMed ID: 9005471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia.
    Su TY; Ye JJ; Hsu PC; Wu HF; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2015 Apr; 48(2):175-82. PubMed ID: 24064286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Microb Drug Resist; 2005; 11(1):68-74. PubMed ID: 15770098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of death with recurrent Pseudomonas aeruginosa bacteremia.
    McCarthy KL; Paterson DL
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):152-157. PubMed ID: 28366610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia.
    Chamot E; Boffi El Amari E; Rohner P; Van Delden C
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2756-64. PubMed ID: 12936970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a combination antibiogram for Pseudomonas aeruginosa bacteremia in an oncology population.
    Smith ZR; Tajchman SK; Dee BM; Bruno JJ; Qiao W; Tverdek FP
    J Oncol Pharm Pract; 2016 Jun; 22(3):409-15. PubMed ID: 25956419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors.
    Grisaru-Soen G; Lerner-Geva L; Keller N; Berger H; Passwell JH; Barzilai A
    Pediatr Infect Dis J; 2000 Oct; 19(10):959-63. PubMed ID: 11055596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.